Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A6

    
• • ·Information for Authors

    Page :A7

    
• • ·Information for Readers

    Page :A9

    

• Results of Expert Meetings

  • ·Postmarket evaluation of breakthrough technologies

    Page :201-208

    Sunil V. Rao, Robert M. Califf, Judith M. Kramer, Eric D. Peterson, Thomas P. Gross, Carl J. Pepine, David O. Williams, Dennis Donohoe, Ron Waksman, Roxana Mehran, Mitchell W. Krucoff

    Résumé Résumé Plan Plan

• Clinical Investigations

  • ·Unfractionated heparin dosing and risk of major bleeding in non–ST-segment elevation acute coronary syndromes

    Page :209-215

    Chiara Melloni, Karen P. Alexander, Anita Y. Chen, L. Kristin Newby, Matthew T. Roe, Nancy M. Allen LaPointe, Charles V. Pollack, W. Brian Gibler, E. Magnus Ohman, Eric D. Peterson, for the CRUSADE Investigators

    Résumé Résumé Plan Plan  
  • ·Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: A systematic review and meta-analysis of randomized controlled trials

    Page :216

    Ahmed Abdel-Latif, Roberto Bolli, Ewa K. Zuba-Surma, Imad M. Tleyjeh, Carlton A. Hornung, Buddhadeb Dawn

    Résumé Résumé Plan Plan  
  • ·Thirty-year trends (1975-2005) in the magnitude and hospital death rates associated with complete heart block in patients with acute myocardial infarction: A population-based perspective

    Page :227-233

    Hoa L. Nguyen, Darleen Lessard, Frederick A. Spencer, Jorge Yarzebski, Juan C. Zevallos, Joel M. Gore, Robert J. Goldberg

    Résumé Résumé Plan Plan  
  • ·Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting

    Page :234-240

    Terry R. Ketch, Samuel J. Turner, Matthew T. Sacrinty, Kevin C. Lingle, Robert J. Applegate, Michael A. Kutcher, David C. Sane

    Résumé Résumé Plan Plan  
  • ·Verapamil-sustained release–based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: An INternational VErapamil SR-Trandolapril (INVEST) substudy

    Page :241-247

    Sripal Bangalore, Franz H. Messerli, Jerome D. Cohen, Peter H. Bacher, Peter Sleight, Giuseppe Mancia, Peter Kowey, Qian Zhou, Annette Champion, Carl J. Pepine, for the INVEST Investigators

    Résumé Résumé Plan Plan  
  • ·Spontaneous reperfusion in ST-elevation myocardial infarction: Comparison of angiographic and electrocardiographic assessments

    Page :248-255

    Kevin R. Bainey, Yuling Fu, Galen S. Wagner, Shaun G. Goodman, Allan Ross, Christopher B. Granger, Frans Van de Werf, Paul W. Armstrong, for the ASSENT 4 PCI Investigators

    Résumé Résumé Plan Plan  
  • ·Correction

    Page :255

    
  • ·Incidence and clinical impact of right bundle branch block in patients with acute myocardial infarction: ST elevation myocardial infarction versus non-ST elevation myocardial infarction

    Page :256-261

    Thomas Kleemann, Claus Juenger, Anselm Kai Gitt, Rudolf Schiele, Steffen Schneider, Jochen Senges, Harald Darius, Karlheinz Seidl, for the MITRA PLUS Study Group

    Résumé Résumé Plan Plan  
  • ·Impact of delayed presentation on management and outcome of non–ST-elevation acute coronary syndromes

    Page :262-268

    Basem Elbarouni, Shaun G. Goodman, Raymond T. Yan, Amparo Casanova, Abdul Al-Hesayen, Stephen Pearce, David H. Fitchett, Anatoly Langer, Andrew T. Yan, for the Canadian ACS Registries Investigators

    Résumé Résumé Plan Plan  
  • ·Additive prognostic value of interleukin-6 at peak phase of dobutamine stress echocardiography in patients with coronary artery disease. A 6-year follow-up study

    Page :269-276

    Ignatios Ikonomidis, George Athanassopoulos, Kimon Stamatelopoulos, John Lekakis, Ioanna Revela, Kiriaki Venetsanou, Margarita Marinou, Claudia Monaco, Dennis V. Cokkinos, Petros Nihoyannopoulos

    Résumé Résumé Plan Plan  
  • ·Correction

    Page :276

    Ann-Dorthe Olsen Zwisler

    
  • ·Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality

    Page :277-283

    Peter A. McCullough, Suying Li, Claudine T. Jurkovitz, Leslie Stevens, Alan J. Collins, Shu-Cheng Chen, Keith C. Norris, Samy McFarlane, Bruce Johnson, Michael G. Shlipak, Chamberlain I. Obialo, Wendy W. Brown, Joseph Vassaloti, Adam T. Whaley-Connell, Robert M. Brenner, George L. Bakris, on behalf of the KEEP Investigators

    Résumé Résumé Plan Plan  
  • ·National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002

    Page :284-291

    Michael W. Cullen, James H. Stein, Ronald Gangnon, Patrick E. McBride, Jon G. Keevil

    Résumé Résumé Plan Plan  
  • ·Peak aerobic capacity predicts prognosis in patients with coronary heart disease

    Page :292-300

    Steven J. Keteyian, Clinton A. Brawner, Patrick D. Savage, Jonathan K. Ehrman, John Schairer, George Divine, Heather Aldred, Kristin Ophaug, Philip A. Ades

    Résumé Résumé Plan Plan  
  • ·The relationship between gender and clinical management after exercise stress testing

    Page :301-307

    Stacie L. Daugherty, Pamela N. Peterson, David J. Magid, P. Michael Ho, Jessica Bondy, John E. Hokanson, Colleen A. Ross, John S. Rumsfeld, Frederick A. Masoudi

    Résumé Résumé Plan Plan  
  • ·Comparison of 8 biomarkers for prediction of right ventricular hypokinesis 6 months after submassive pulmonary embolism

    Page :308-314

    Jeffrey A. Kline, Raghid Zeitouni, Michael R. Marchick, Jackeline Hernandez-Nino, Geoffrey A. Rose

    Résumé Résumé Plan Plan
  • ·Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: Evidence of improved vascular ?₁-adrenoreceptor signal transduction

    Page :315-321

    Benjamin W. Van Tassell, Matthew T. Rondina, Franklin Huggins, Edward M. Gilbert, Mark A. Munger

    Résumé Résumé Plan Plan  
  • ·Short-term mortality and cost associated with cardiac device implantation in patients hospitalized with heart failure

    Page :322-328

    Jason Swindle, Thomas E. Burroughs, Mark A. Schnitzler, Paul J. Hauptman

    Résumé Résumé Plan Plan  
  • ·Predictive power of systolic function and congestive heart failure in patients with patients admitted for chest pain without ST elevation in the troponin era

    Page :329-335

    Michael C. Kontos, Sameer Jamal, James L. Tatum, Joseph P. Ornato, Robert L. Jesse

    Résumé Résumé Plan Plan  
  • ·Tumor necrosis factor-? antagonist use and heart failure in elderly patients with rheumatoid arthritis

    Page :336-341

    Soko Setoguchi, Sebastian Schneeweiss, Jerry Avorn, Jeffrey N. Katz, Michael E. Weinblatt, Raisa Levin, Daniel H. Solomon

    Résumé Résumé Plan Plan  
  • ·Clinical characteristics and outcomes of patients with hypertrophic cardiomyopathy with latent obstruction

    Page :342-347

    Joseph C. Vaglio, Steve R. Ommen, Rick A. Nishimura, A. Jamil Tajik, Bernard J. Gersh

    Résumé Résumé Plan Plan  
  • ·A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis

    Page :348-355

    Ralph A.H. Stewart, Andrew J. Kerr, Brett R. Cowan, Alistair A. Young, Christopher Occleshaw, A. Mark Richards, Colin Edwards, Gillian A. Whalley, Denis Freidlander, Miles Williams, Robert N. Doughty, Irene Zeng, Harvey D. White, for the ZEST Study Investigators i

    Résumé Résumé Plan Plan  
  • ·Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: Periprocedural results and midterm risk of recurrent neurologic events

    Page :356-360

    Manrico Balbi, Laura Casalino, Giovanni Gnecco, Gian Paolo Bezante, Giacomo Pongiglione, Maurizio Marasini, Massimo Del Sette, Antonio Barsotti

    Résumé Résumé Plan Plan
  • ·Impact of concomitant aortic regurgitation on percutaneous mitral valvuloplasty: Immediate results, short-term, and long-term outcome

    Page :361-366

    Maria Sanchez-Ledesma, Ignacio Cruz-Gonzalez, Pedro L. Sanchez, Javier Martin-Moreiras, Hani Jneid, Pablo Rengifo-Moreno, Roberto J. Cubeddu, Ignacio Inglessis, Andrew O. Maree, Igor F. Palacios

    Résumé Résumé Plan Plan  
  • ·Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy

    Page :367-372

    Christine M. Albert, Rebecca Quigg, Samir Saba, N.A. Mark Estes, Andi Shaechter, Haris Subacius, Adam Howard, Joseph Levine, Alan Kadish, for the DEFINITE Investigators f

    Résumé Résumé Plan Plan  
  • ·The Drug And Pace Health cliNical Evaluation (DAPHNE) study: A randomized trial comparing sotalol versus ?-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker

    Page :373.e1

    Alessandro Capucci, GianLuca Botto, Giulio Molon, Andrea Spampinato, Stefano Favale, Alessandro Proclemer, Antonio Porfilio, Tiziana Marotta, Marco Vimercati, Giuseppe Boriani, on behalf of the DAPHNE study investigators j

    Résumé Résumé Plan Plan  
  • ·The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery

    Page :373.e9

    Young Bin Song, Young Keun On, Jun Hyung Kim, Dae-Hee Shin, June Soo Kim, Jidong Sung, Sang Hoon Lee, Wook Sung Kim, Young Tak Lee

    Résumé Résumé Plan Plan  
  • ·Health status outcomes after cardioversion for atrial fibrillation: Results from the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Trial

    Page :374.e1

    Daniel J. Elliott, Liping Zhao, Susan E. Jasper, Elizabeth A. Lieber, Allan L. Klein, William S. Weintraub

    Résumé Résumé Plan Plan  
  • ·Usefulness of 64-slice multidetector computed tomography as an initial diagnostic approach in patients with acute chest pain

    Page :375-383

    Sung-A Chang, Sang Il Choi, Eue-Keun Choi, Hyung-Kwan Kim, Jin-Wook Jung, Eun Ju Chun, Kyu-Seok Kim, Young-Seok Cho, Woo-Young Chung, Tae-Jin Youn, In-Ho Chae, Dong-Ju Choi, Hyuk-Jae Chang

    Résumé Résumé Plan Plan  
  • ·Echocardiographic predictors of mitral stenosis–related death or intervention in infants

    Page :384-390

    Elif Seda Selamet Tierney, Dionne A. Graham, Doff B. McElhinney, Shari Trevey, Michael D. Freed, Steven D. Colan, Tal Geva

    Résumé Résumé Plan Plan  
  • ·Long-term outcome of primary angioplasty compared with fibrinolysis across age groups: A Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI-2) substudy

    Page :391-396

    Emil Loldrup Fosbøl, Jens Jakob Thune, Henning Kelbæk, Henning Rud Andersen, Kari Saunamäki, Torsten Toftegaard Nielsen, Leif Spange Mortensen, Lars Køber, for the DANAMI-2 investigators

    Résumé Résumé Plan Plan  
  • ·?-Adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: Results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES)

    Page :397-404

    Tobias Gerhard, Yan Gong, Amber L. Beitelshees, Xianyun Mao, Maximilian T. Lobmeyer, Rhonda M. Cooper-DeHoff, Taimour Y. Langaee, Nicholas J. Schork, Mark D. Shriver, Carl J. Pepine, Julie A. Johnson, for the INVEST Investigators

    Résumé Résumé Plan Plan  
  • ·Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: The Northern Manhattan Study (NOMAS)

    Page :405-410

    Takeki Suzuki, Kumiko Hirata, Mitchell S.V. Elkind, Zhezhen Jin, Tanja Rundek, Yumiko Miyake, Bernadette Boden-Albala, Marco R. Di Tullio, Ralph Sacco, Shunichi Homma

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Lipophilicity and cardiovascular outcome in patients with CHF

    Page :e7

    John S. Ford, John A. Tayek

    
  • ·Response to the letter

    Page :e9

    Stéphanie Rinfret, Hassan Behlouli, Louise Pilote

    
  • ·What do we mean by “outcome can be predicted”?

    Page :e11

    Michael T. Koller, Andrew Vickers, Ewout W. Steyerberg

     
  • ·Predicting serious renal dysfunction—a prophylactic approach

    Page :e13

    Jeremiah R. Brown, Todd A. MacKenzie, David J. Malenka, For the Northern New England Cardiovascular Disease Study Group

    
  • ·Letter to the editor

    Page :e15

    Pablo Aguiar-Souto, Sara Valero-González

    
  • ·Pre-procedural risk stratification—Why wait?

    Page :e17

    Jeremiah R. Brown, Winthrop D. Piper, David J. Malenka, for the Northern New England Cardiovascular Disease Study Group

    
  • ·The pathophysiology of acute heart failure: The key role of fluid accumulation

    Page :e19

    Gaspare Parrinello, Daniele Torres, Salvatore Paterna, Pietro di Pasquale, Giuseppe Licata